Reni Benjamin
Stock Analyst at Citizens JMP
(0.06)
# 4,691
Out of 4,969 analysts
793
Total ratings
35.2%
Success rate
-8.7%
Average return
Main Sectors:
Stocks Rated by Reni Benjamin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IOVA Iovance Biotherapeutics | Reiterated: Buy | $5 → $8 | $8.60 | -6.98% | 50 | Aug 7, 2026 | |
| ONC BeOne Medicines AG | Reiterated: Buy | $396 → $405 | $346.51 | +16.88% | 11 | Aug 6, 2026 | |
| STRO Sutro Biopharma | Reiterated: Buy | $35 → $41 | $16.86 | +143.18% | 47 | Apr 23, 2026 | |
| WHWK Whitehawk Therapeutics | Initiated Coverage: Buy | $8 | $4.11 | +94.65% | 1 | Apr 16, 2026 | |
| ALLO Allogene Therapeutics | Reiterated: Buy | $5 → $8 | $1.78 | +349.44% | 36 | Apr 14, 2026 | |
| BCYC Bicycle Therapeutics | Reiterated: Buy | $12 → $8 | $3.86 | +107.25% | 37 | Mar 18, 2026 | |
| IMMP Immutep | Downgraded: Hold | n/a | $0.3733 | - | 2 | Mar 13, 2026 | |
| PRLD Prelude Therapeutics | Reiterated: Buy | $3 → $6 | $4.59 | +30.72% | 15 | Mar 11, 2026 | |
| IMMX Immix Biopharma | Initiated Coverage: Buy | $23 | $12.14 | +89.46% | 1 | Mar 9, 2026 | |
| LYEL Lyell Immunopharma | Initiated Coverage: Buy | $34 | $11.96 | +184.28% | 1 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $31 | $22.62 | +37.05% | 1 | Jan 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.982 | - | 12 | Dec 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $2.00 | +400.00% | 1 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $32 | $26.24 | +21.95% | 1 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $8 | $3.13 | +155.59% | 16 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $9.52 | - | 28 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $11.39 | +110.71% | 41 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $121.47 | - | 105 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $17.55 | n/a | 8 | Sep 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $7.32 | n/a | 7 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $109.27 | n/a | 6 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 | $28.74 | n/a | 27 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.47 | n/a | 10 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0008 | n/a | 12 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.00 | n/a | 12 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $7.32 | n/a | 20 | May 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $6 | $0.02265 | n/a | 19 | May 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.00 | n/a | 24 | May 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $110 | $65.68 | n/a | 1 | Apr 9, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $5 | $1.01 | n/a | 5 | Mar 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $73 → $57 | $42.31 | n/a | 14 | Mar 1, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $96 → $94 | $8.53 | n/a | 12 | Feb 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 | $0.9517 | n/a | 4 | Dec 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $5 | $1.51 | n/a | 25 | Nov 15, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $3.19 | n/a | 9 | Nov 14, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $10 | $9.23 | n/a | 17 | Oct 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $13 | $2.27 | n/a | 16 | Aug 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $53.89 | n/a | 25 | Aug 14, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.2831 | n/a | 8 | Aug 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.31 | n/a | 21 | Aug 7, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $7.91 | n/a | 14 | Aug 7, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $11.55 | n/a | 10 | Dec 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.03156 | n/a | 7 | Jun 4, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $0.00795 | n/a | 1 | May 26, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $1.47 | n/a | 7 | May 21, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0001 | n/a | 5 | May 15, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $3 | $2.33 | n/a | 5 | Mar 31, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $5 | $1.03 | n/a | 6 | Mar 31, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $12 | $8.37 | n/a | 7 | Mar 19, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.18 | n/a | 4 | Feb 18, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $6.94 | n/a | 6 | Jan 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $0.00001 | n/a | 6 | Dec 11, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.06 | n/a | 3 | Oct 13, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $17 | $36.59 | n/a | 1 | May 5, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $39 | $20.45 | n/a | 1 | Jul 24, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $1.35 | n/a | 2 | Oct 12, 2010 |
Iovance Biotherapeutics
Aug 7, 2026
Reiterated: Buy
Price Target: $5 → $8
Current: $8.60
Upside: -6.98%
BeOne Medicines AG
Aug 6, 2026
Reiterated: Buy
Price Target: $396 → $405
Current: $346.51
Upside: +16.88%
Sutro Biopharma
Apr 23, 2026
Reiterated: Buy
Price Target: $35 → $41
Current: $16.86
Upside: +143.18%
Whitehawk Therapeutics
Apr 16, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $4.11
Upside: +94.65%
Allogene Therapeutics
Apr 14, 2026
Reiterated: Buy
Price Target: $5 → $8
Current: $1.78
Upside: +349.44%
Bicycle Therapeutics
Mar 18, 2026
Reiterated: Buy
Price Target: $12 → $8
Current: $3.86
Upside: +107.25%
Immutep
Mar 13, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.3733
Upside: -
Prelude Therapeutics
Mar 11, 2026
Reiterated: Buy
Price Target: $3 → $6
Current: $4.59
Upside: +30.72%
Immix Biopharma
Mar 9, 2026
Initiated Coverage: Buy
Price Target: $23
Current: $12.14
Upside: +89.46%
Lyell Immunopharma
Mar 9, 2026
Initiated Coverage: Buy
Price Target: $34
Current: $11.96
Upside: +184.28%
Jan 29, 2026
Initiated Coverage: Buy
Price Target: $31
Current: $22.62
Upside: +37.05%
Dec 19, 2025
Downgraded: Hold
Price Target: n/a
Current: $0.982
Upside: -
Dec 3, 2025
Initiated Coverage: Buy
Price Target: $10
Current: $2.00
Upside: +400.00%
Dec 3, 2025
Initiated Coverage: Buy
Price Target: $32
Current: $26.24
Upside: +21.95%
Oct 30, 2025
Reiterated: Buy
Price Target: $5 → $8
Current: $3.13
Upside: +155.59%
Oct 8, 2025
Reiterated: Hold
Price Target: n/a
Current: $9.52
Upside: -
Sep 30, 2025
Reiterated: Buy
Price Target: $24
Current: $11.39
Upside: +110.71%
Sep 18, 2025
Reiterated: Hold
Price Target: n/a
Current: $121.47
Upside: -
Sep 8, 2025
Reiterated: Buy
Price Target: $40
Current: $17.55
Upside: n/a
Aug 15, 2025
Reiterated: Hold
Price Target: n/a
Current: $7.32
Upside: n/a
May 15, 2025
Reiterated: Hold
Price Target: n/a
Current: $109.27
Upside: n/a
Apr 21, 2025
Reiterated: Buy
Price Target: $2
Current: $28.74
Upside: n/a
Apr 6, 2023
Rated: Hold
Price Target: n/a
Current: $2.47
Upside: n/a
Apr 6, 2023
Rated: Hold
Price Target: n/a
Current: $0.0008
Upside: n/a
Apr 6, 2023
Rated: Hold
Price Target: n/a
Current: $7.00
Upside: n/a
May 10, 2019
Downgraded: Hold
Price Target: n/a
Current: $7.32
Upside: n/a
May 7, 2019
Reiterated: Buy
Price Target: $16 → $6
Current: $0.02265
Upside: n/a
May 2, 2019
Reiterated: Hold
Price Target: n/a
Current: $4.00
Upside: n/a
Apr 9, 2019
Initiated Coverage: Buy
Price Target: $110
Current: $65.68
Upside: n/a
Mar 18, 2019
Reiterated: Buy
Price Target: $6 → $5
Current: $1.01
Upside: n/a
Mar 1, 2019
Reiterated: Buy
Price Target: $73 → $57
Current: $42.31
Upside: n/a
Feb 5, 2019
Upgraded: Buy
Price Target: $96 → $94
Current: $8.53
Upside: n/a
Dec 13, 2018
Reiterated: Buy
Price Target: $21
Current: $0.9517
Upside: n/a
Nov 15, 2018
Upgraded: Buy
Price Target: $5
Current: $1.51
Upside: n/a
Nov 14, 2018
Upgraded: Buy
Price Target: n/a
Current: $3.19
Upside: n/a
Oct 12, 2018
Reiterated: Buy
Price Target: $11 → $10
Current: $9.23
Upside: n/a
Aug 28, 2018
Reiterated: Buy
Price Target: $13 → $13
Current: $2.27
Upside: n/a
Aug 14, 2018
Reiterated: Buy
Price Target: $22
Current: $53.89
Upside: n/a
Aug 10, 2018
Reiterated: Hold
Price Target: n/a
Current: $0.2831
Upside: n/a
Aug 7, 2018
Reiterated: Hold
Price Target: n/a
Current: $2.31
Upside: n/a
Aug 7, 2018
Reiterated: Hold
Price Target: n/a
Current: $7.91
Upside: n/a
Dec 18, 2017
Rated: Hold
Price Target: n/a
Current: $11.55
Upside: n/a
Jun 4, 2015
Reiterated: Buy
Price Target: $6
Current: $0.03156
Upside: n/a
May 26, 2015
Initiated Coverage: Buy
Price Target: $13
Current: $0.00795
Upside: n/a
May 21, 2015
Reiterated: Buy
Price Target: $8
Current: $1.47
Upside: n/a
May 15, 2015
Downgraded: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Mar 31, 2015
Reiterated: Buy
Price Target: $7 → $3
Current: $2.33
Upside: n/a
Mar 31, 2015
Reiterated: Buy
Price Target: $9 → $5
Current: $1.03
Upside: n/a
Mar 19, 2015
Reiterated: Buy
Price Target: $8 → $12
Current: $8.37
Upside: n/a
Feb 18, 2015
Reiterated: Buy
Price Target: $4
Current: $1.18
Upside: n/a
Jan 9, 2015
Reiterated: Buy
Price Target: $6
Current: $6.94
Upside: n/a
Dec 11, 2014
Reiterated: Buy
Price Target: $40
Current: $0.00001
Upside: n/a
Oct 13, 2014
Reiterated: Hold
Price Target: n/a
Current: $2.06
Upside: n/a
May 5, 2014
Initiated Coverage: Buy
Price Target: $17
Current: $36.59
Upside: n/a
Jul 24, 2013
Downgraded: Hold
Price Target: $39
Current: $20.45
Upside: n/a
Oct 12, 2010
Reiterated: Buy
Price Target: $9
Current: $1.35
Upside: n/a